O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.
Middleton MR. et al, (1998), Br J Cancer, 78, 1199 - 1202
A randomized phase II trial of interleukin 2 and interleukin 2-interferon alpha in advanced renal cancer.
Jayson GC. et al, (1998), Br J Cancer, 78, 366 - 369
Dose intensity in small cell lung cancer
Thatcher N. et al, (1998), Seminars in Oncology, 25, 12 - 18
Dose intensity in small cell lung cancer
Thatcher N. et al, (1998), SEMINARS IN ONCOLOGY, 25, 12 - 18
Encephalopathy and haemorrhagic mucositis after high-dose melphalan with peripheral blood stem cell rescue in two patients with impaired renal function
Schuh AH. et al, (1998), BONE MARROW TRANSPLANTATION, 21, S202 - S202
Consequences of GATA-1 deficiency in megakaryocytes and platelets.
Vyas P. et al, (1998), BLOOD, 92, 195A - 195A
Dose intensification in small cell lung cancer chemotherapy
Middleton MR. and Thatcher N., (1998), Emerging Drugs, 3, 293 - 302
Hippocampal and cortical G protein (Gs alpha, G(o) alpha and Gi2 alpha) mRNA expression after electroconvulsive shock or lithium carbonate treatment.
McGowan S. et al, (1996), Eur J Pharmacol, 306, 249 - 255
Repeated ECS differentially affects rat brain 5-HT1A and 5-HT2A receptor expression.
Burnet PW. et al, (1995), Neuroreport, 6, 901 - 904